The quality of a patent begins to take shape at the time of disclosure. An inadequate disclosure can greatly affect the quality of the patent. The level of sophistication of a client typically ...

"'In re Cellect' and the USPTO’s proposed rule have the potential to fundamentally affect patent practice, particularly in the realm of terminal disclaimers filed to overcome ODP rejections," write ...

“The tension between patents and trade dress protection is most evident when the alleged trade dress (or aspects thereof) has been disclosed in a utility patent.” Patents and trademarks protect ...

International patent protection was a key issue at the multilateral trade talkssponsored by the World Trade Organization in Cancun in September 2003. Indeed,since the organization was founded almost ...

While Linux and open-source software (OSS) are no longer constantly under intellectual property (IP) attacks, the Open Invention Network (OIN) patent consortium still stands guard over its patents.

The listing of patents in the Orange Book has an important role in intellectual property protection for pharmaceuticals. Patents listed in the Orange Book can include, without question, patents ...

This week on IPWatchdog Unleashed we will explore the age-old question about whether it is best to keep an innovation as a trade secret or if it makes sense to seek patent protection. And while this ...

As legislation reshaping Myanmar’s intellectual property landscape comes into force, Khin Myo Myo Aye and Yuwadee Thean-ngarm of Tilleke & Gibbins outline the key provisions and consider the ...

New patent granted in China for pharmaceutical composition of NT219 expands IP protection REHOVOT, Israel, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Company") ...

Advances in molecular diagnostics and genetic mapping are ushering in the era of personalized medicine. Although medicine has always considered each patient individually, personalized medicine enables ...

PRESS RELEASEAB SCIENCE RECEIVES JAPANESE PATENT PROTECTION FOR THE USE OF MASITINIB IN PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS (MS) UNTIL ...